Mortimer Ian
CIK 0001619961
PRESIDENT, CEO & INTERIM CFODirector
Filings
13
Latest Mar 13, 2026
Issuers covered
1
Showing
13 of 13
Page 1
Track record
25 of 25 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 25 | 92% | +4.8% | +5.4% | +8.3% | -7.2% |
| 90 days | 14 | 57% | -7.2% | +5.0% | +7.3% | -40.9% |
| 180 days | 10 | 70% | +9.7% | +22.4% | +29.7% | -42.0% |
| 365 days | 7 | 43% | -0.0% | -4.5% | +7.1% | -5.7% |
Issuers
Companies where Mortimer Ian has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 13 | Mar 13, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|